All In MedTech

Device Trial Radar · NCT06465745

ATLAS (AltaValve) Pivotal Trial

ATLAS (A Transseptal Left Atrial System for Treatment of Mitral Regurgitation) Pivotal Trial

Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Sep 3, 2024

Primary completion

Sep 2029

Study completion Sep 2031

Sponsor

Lead sponsor
4C Medical Technologies, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 20, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

Conditions

  • Mitral Regurgitation
  • Mitral Insufficiency
  • Mitral Valve Incompetence
  • Mitral Valve Regurgitation
  • Mitral Incompetence

Interventions

  • AltaValve System.Device

    Transcatheter Mitral Valve Replacement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite of all-cause mortality or heart failure hospitalization.Time frame: 12 months.

Locations

58 sites in 7 countries. Site status is shown where the registry gives one.

  • Banner University Medical Center

    Phoenix, Arizona · Recruiting

  • Abrazo Arizona Heart Hospital

    Phoenix, Arizona · Recruiting

  • Dignity Health; St. Joseph's Hospital and Medical Center

    Phoenix, Arizona · Recruiting

55 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.